The estimated Net Worth of Jennifer Schneider is at least $42.4 Milion dollars as of 3 September 2020. Jennifer Schneider owns over 60,266 units of Livongo Health stock worth over $37,520,278 and over the last 5 years Jennifer sold LVGO stock worth over $4,888,277.
Jennifer has made over 8 trades of the Livongo Health stock since 2019, according to the Form 4 filled with the SEC. Most recently Jennifer exercised 60,266 units of LVGO stock worth $48,213 on 3 September 2020.
The largest trade Jennifer's ever made was exercising 60,266 units of Livongo Health stock on 3 September 2020 worth over $48,213. On average, Jennifer trades about 9,962 units every 15 days since 2019. As of 3 September 2020 Jennifer still owns at least 268,443 units of Livongo Health stock.
You can see the complete history of Jennifer Schneider stock trades at the bottom of the page.
Jennifer's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.
Over the last 5 years, insiders at Livongo Health have traded over $82,400,328 worth of Livongo Health stock and bought 11,181,508 units worth $313,072,144 . The most active insiders traders include Hemant Taneja, Joel E Cutler oraz Glen Tullman. On average, Livongo Health executives and independent directors trade stock every 12 days with the average trade being worth of $49,555,733. The most recent stock trade was executed by Philip D Green on 27 October 2020, trading 85,415 units of LVGO stock currently worth $135,810.
Livongo Health, Inc. engages in the development and operation of consumer digital health platform. It offers Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008 and is headquartered in Mountain View, CA.
Livongo Health executives and other stock owners filed with the SEC include: